India Drug Delivery Devices Market Outlook to 2023-Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices

India Drug Delivery Devices Market Outlook to 2023-Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices


  • Products Id :- GDMEMC0250DB
  • |
  • Pages: 143
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

India Drug Delivery Devices Market Outlook to 2023-Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices

Summary

GlobalData's new report, "India Drug Delivery Devices Market Outlook to 2023", provides key market data on the India Drug Delivery Devices market. The report provides value, in millions of US dollars and volume (in units) within market categories-Central Venous Catheters, Needle Free Injections, Infusion Systems and Metered Dose Inhaler Devices.

The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

Market size and company share data for Drug Delivery Devices market categories-Central Venous Catheters, Needle Free Injections, Infusion Systems and Metered Dose Inhaler Devices.

Annualized market revenues (USD million) and volume (units) data for each of the market categories. Data is provided from 2009 to 2016 and forecast to 2023.

2016 company shares and distribution shares data for each of the market categories.

Global corporate-level profiles of key companies operating within the India Drug Delivery Devices market.

Key players covered include GlaxoSmithKline Plc, AstraZeneca Plc, Hospira Inc, Becton Dickinson and Co, Boehringer Ingelheim GmbH, Baxter International Inc, Medtronic plc and others.

Reasons to buy

Develop business strategies by identifying the key market categories poised for strong growth in the future.

Develop market-entry and market expansion strategies.

Design competition strategies by identifying who-stands-where in the market.

Develop investment strategies by identifying the key market categories expected to register strong growth in the near future.

What are the key distribution channels and what's the most preferred mode of product distribution-Identify, understand and capitalize.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 6

1.2 List of Figures 7

2 Introduction 8

2.1 What Is This Report About? 8

2.2 Drug Delivery Devices Market Segmentation 8

2.3 Definitions of Markets Covered in the Report 9

3 Drug Delivery Devices Market, India 12

3.1 Drug Delivery Devices Market, India, Revenue ($m), 2009-2023 12

3.2 Drug Delivery Devices Market, India, Revenue Mix ($m), 2016 14

3.3 Drug Delivery Devices Market, India, Category Contribution by Revenue ($m), 2016 15

3.4 Drug Delivery Devices Market, India, Category Comparison by Revenue ($m), 2009-2023 16

3.5 Drug Delivery Devices Market, India, Revenue ($m), 2009-2016 17

3.6 Drug Delivery Devices Market, India, Revenue ($m), 2016-2023 19

3.7 Drug Delivery Devices Market, India, Volume (Units), 2009-2023 21

3.8 Drug Delivery Devices Market, India, Volume (Units), 2009-2016 23

3.9 Drug Delivery Devices Market, India, Volume (Units), 2016-2023 25

3.10 Drug Delivery Devices Market, India, Company Share by Revenue ($m), 2016 27

4 Central Venous Catheters Market, India 29

4.1 Central Venous Catheters Market, India, Revenue Mix ($m), 2016 29

4.2 Central Venous Catheters Market, India, Segment Contribution (%), 2016 30

4.3 Central Venous Catheters Market, India, Revenue ($m), 2009-2016 31

4.4 Central Venous Catheters Market, India, Revenue ($m), 2016-2023 33

4.5 Central Venous Catheters Market, India, Volume (Units), 2009-2016 35

4.6 Central Venous Catheters Market, India, Volume (Units), 2016-2023 37

4.7 Central Venous Catheters Market, India, Distribution Share by Revenue ($m), 2015-2016 39

4.8 Central Venous Catheters Market, India, Company Share by Revenue ($m), 2016 40

5 Infusion Systems Market, India 42

5.1 Infusion Systems Market, India, Revenue Mix ($m), 2016 42

5.2 Infusion Systems Market, India, Segment Contribution (%), 2016 43

5.3 Infusion Systems Market, India, Revenue ($m), 2009-2016 45

5.4 Infusion Systems Market, India, Revenue ($m), 2016-2023 47

5.4.1 Ambulatory Infusion Pumps Market, India, Revenue ($m), by Segment, 2009-2016 49

5.4.2 Syringe Pumps Market, India, Revenue ($m), by Segment, 2009-2016 51

5.4.3 Ambulatory Infusion Pumps Market, India, Revenue ($m), by Segment, 2016-2023 53

5.4.4 Syringe Pumps Market, India, Revenue ($m), by Segment, 2016-2023 55

5.5 Infusion Systems Market, India, Volume (Units), 2009-2016 57

5.6 Infusion Systems Market, India, Volume (Units), 2016-2023 59

5.6.1 Ambulatory Infusion Pumps Market, India, Volume (Units), by Segment, 2009-2016 61

5.6.2 Syringe Pumps Market, India, Volume (Units), by Segment, 2009-2016 63

5.6.3 Ambulatory Infusion Pumps Market, India, Volume (Units), by Segment, 2016-2023 65

5.6.4 Syringe Pumps Market, India, Volume (Units), by Segment, 2016-2023 67

5.7 Infusion Systems Market, India, Distribution Share by Revenue ($m), 2015-2016 69

5.8 Infusion Systems Market, India, Company Share by Revenue ($m), 2016 70

6 Needle Free Injections Market, India 72

6.1 Needle Free Injections Market, India, Revenue ($m), 2009-2016 72

6.2 Needle Free Injections Market, India, Revenue ($m), 2016-2023 73

6.3 Needle Free Injections Market, India, Volume (Units), 2009-2016 74

6.4 Needle Free Injections Market, India, Volume (Units), 2016-2023 75

6.5 Needle Free Injections Market, India, Distribution Share by Revenue ($m), 2015-2016 76

6.6 Needle Free Injections Market, India, Company Share by Revenue ($m), 2016 77

7 Metered Dose Inhaler Devices Market, India 79

7.1 Metered Dose Inhaler Devices Market, India, Revenue ($m), 2009-2016 79

7.2 Metered Dose Inhaler Devices Market, India, Revenue ($m), 2016-2023 80

7.3 Metered Dose Inhaler Devices Market, India, Volume (Units), 2009-2016 81

7.4 Metered Dose Inhaler Devices Market, India, Volume (Units), 2016-2023 82

7.5 Metered Dose Inhaler Devices Market, India, Distribution Share by Revenue ($m), 2015-2016 83

7.6 Metered Dose Inhaler Devices Market, India, Company Share by Revenue ($m), 2016 84

8 Overview of Key Companies in India, Drug Delivery Devices Market 86

8.1 Teleflex Inc 86

8.1.1 Company Overview 86

8.2 GlaxoSmithKline Plc 86

8.2.1 Company Overview 86

8.3 B. Braun Melsungen AG 86

8.3.1 Company Overview 86

8.4 Baxter International Inc 86

8.4.1 Company Overview 86

8.5 AstraZeneca Plc 87

8.5.1 Company Overview 87

8.6 Boehringer Ingelheim GmbH 87

8.6.1 Company Overview 87

8.7 Fresenius Kabi AG 87

8.7.1 Company Overview 87

8.8 Pfizer Inc 87

8.8.1 Company Overview 87

8.9 Smiths Medical 88

8.9.1 Company Overview 88

8.10 Merck & Co Inc 88

8.10.1 Company Overview 88

8.11 Cipla Ltd 88

8.11.1 Company Overview 88

8.12 Hospira Inc 89

8.12.1 Company Overview 89

8.12 Terumo Corp 89

8.12.1 Company Overview 89

8.19 Becton Dickinson and Co 89

8.19.1 Company Overview 89

8.13 Medtronic Plc 89

8.13.1 Company Overview 89

8.14 Nipro Corp 90

8.14.1 Company Overview 90

9 Drug Delivery Devices Market Pipeline Products 91

10 Financial Deals Landscape 96

10.1 Acquisition 96

10.1.1 Pinfold Overseas Acquires Additional 6.4% Stake in Morepen Labs 96

10.2 Asset Transactions 97

10.2.1 Eurolife Healthcare Acquires Form-Fill-Seal Infusion Business from Baxter 97

10.2.2 ICU Medical Acquires Hospira Infusion Systems Business from Pfizer 98

10.3 Equity Offerings 100

10.3.1 Piramal Enterprises Plans to Raise Up to USD774.6 Million in Issue of Securities 100

10.4 Partnerships 101

10.4.1 Sayre Therapeutics Enters into Licensing Agreement with Navidea Biopharma 101

10.4.2 PharmaJet Enters into Agreement with Serum Institute of India 102

10.4.3 Aequus Pharma to Enter into Licensing Agreement with Transdermal Research Pharm Labs 103

10.4.4 Valeant Pharma Enters into Licensing Agreement with EyeGate Pharma 104

10.4.5 Eris Lifesciences Enters into Distribution Agreement with India Medtronic 106

10.4.6 Pfizer Terminates its Licensing Agreement with pSivida 107

10.4.7 Bayer Enters into Licensing Agreement with DelSiTech 108

10.4.8 BioCorRx Enters into Licensing Agreement with Therakine 109

11 Recent Developments 110

11.1 Corporate Communications 110

11.1.1 Jul 12, 2017: Sun Pharmaceutical Industries Announces Appointment of Mr. Kalyansundaram Subramanian as the Director 110

11.1.2 Jun 09, 2017: Poly Medicure announces appointment of Chief Operating Officer 110

11.1.3 Apr 12, 2017: Sanofi appoints Nikhilesh Kalra to lead Consumer Healthcare business for India and South Asia 110

11.1.4 Mar 20, 2017: Piramal Pharma Solutions Names Stuart E. Needleman as Chief Commercial Officer 110

11.1.5 Feb 08, 2017: Cipla Updates Appoints Mr. Mital Sanghvi To Senior Business Finance Role 111

11.1.6 Jan 09, 2017: Cipla appoints Peter Lankau as an Independent Director on its Board 111

11.1.7 Nov 29, 2016: Cipla appoints Ireena Vittal as an Independent Director on its Board 112

11.1.8 Nov 10, 2016: Morepen Labs: Appoints Additional Director 112

11.1.9 Aug 12, 2016: Cipla Names Umang Vohra as MD & Global CEO; Samina Vaziralliis Executive Vice-Chairman 112

11.1.10 Aug 01, 2016: Cipla appoints Kedar Upadhye as Global Chief Financial Officer 113

11.2 Financial Announcements 113

11.2.1 May 26, 2017: Sun Pharma reports Q4 & FY17 results 113

11.2.2 May 25, 2017: Cipla announces Q4 & FY 17 results Continued strong performance across key markets 114

11.2.3 May 12, 2017: Dr. Reddy's Q4 and FY17 Financial Results 115

11.2.4 Feb 14, 2017: Sun Pharma reports Q3FY17 results 116

11.2.5 Feb 08, 2017: Morepen labs reports yet another growth-filled quarter 118

11.2.6 Feb 04, 2017: Dr. Reddy's Q3 and 9M FY17 Financial Results 119

11.2.7 Nov 15, 2016: Oncocyte Announces Publication Of Breast Cancer Diagnostic Test Abstract; Poster To Be Presented At The San Antonio Breast Cancer Symposium On December 9, 2016 120

11.2.8 Nov 14, 2016: Medtronic Receives FDA Approval for Claria MRI Quad Cardiac Resynchronization Therapy Defibrillator 121

11.2.9 Nov 14, 2016: With Health Canada approval, Dexcom G5 Mobile CGM System is the First and Only Medical Device in North America for Making Daily Diabetes Decisions Without Painful Fingersticks 122

11.2.10 Nov 11, 2016: CHMP Adopts Positive Opinion to include Self-Administration for RUCONEST 123

11.2.11 Nov 09, 2016: Cipla announces Q2 FY17 results - Improved profitability in base business & Strengthened R&D pipeline 124

11.2.12 Nov 09, 2016: Morepen Labs reports 118 pct jump in net profits for the Q2 of FY 2016-17 125

11.2.13 Oct 25, 2016: Dr. Reddy's Q2 and H1 FY17 Financial Results 125

11.2.14 Aug 12, 2016: Sun Pharma reports Q1FY17 results 127

11.2.15 Aug 12, 2016: Sun Pharmaceutical Industries announces Unaudited results for the Quarter ended 30 th June, 2016 128

11.2.16 Aug 12, 2016: Cipla announces Q1 FY 17 Results Performance reflects continued momentum in key markets and improvement in base EBITDA margins 129

11.2.17 Aug 01, 2016: Piramal Enterprises Consolidated Results for the First Quarter ended 30 June 2016 130

11.2.18 Jul 26, 2016: Dr. Reddy's Q1 FY17 Financial Results 131

11.3 Legal And Regulatory 132

11.3.1 Jun 16, 2017: Dr. Reddy's Laboratories: Update on USFDA Audit 132

11.3.2 Jun 14, 2017: Dr. Reddy's Provides Update on API manufacturing plant at Miryalaguda 132

11.3.3 Jun 01, 2017: Successful AAALAC accreditation for Envigo facilities in Hyderabad, India 133

11.3.4 May 29, 2017: Phosphagenic - Mylan Arbitration Update � expert report on quantum of damages claimed filed 133

11.3.5 May 25, 2017: Dr. Reddy's Laboratories Provides Update on Srikakulum Plant 134

11.3.6 Apr 14, 2017: Dr. Reddy's Provides Update on USFDA Audit 134

11.3.7 Apr 03, 2017: Dr. Reddy's Laboratories Provides Update on USFDA Inspection at Srikakulam plant 134

11.3.8 Mar 14, 2017: Sun Pharma Provides Update on Mohali Facility 134

11.3.9 Mar 14, 2017: Sun Pharmaceutical Industries Provides Update on Mohali Facility 134

11.3.10 Feb 21, 2017: Dr. Reddy's Laboratories Announces US FDA Inspection on Miryalaguda Facility 135

11.3.11 Dec 13, 2016: TUV Certification for the Bengaluru Facility 135

11.3.12 Dec 08, 2016: Sun Pharma Provide Update on USFDA Inspection for Halol facility 135

11.3.13 Sep 30, 2016: Clarification sought from Cipla 135

11.4 Other Significant Developments 136

11.4.1 Feb 08, 2017: Dr. Reddy's Expands Commercial Operations in Europe 136

11.4.2 Jan 10, 2017: Daiichi Sankyo Announces Reorganization of Research & Development System 136

11.5 Product News 136

11.5.1 May 22, 2017: Aptar Pharma to Highlight Drug Delivery Systems Portfolio at FCE Brazil 136

11.6 Strategy And Business Planning 136

11.6.1 Dec 01, 2016: Aptar Pharma Nears Completion Of Elastomer Component Capacity In North America 136

11.6.2 Oct 07, 2016: Leading global pharmaceutical company, Dr. Reddy's Laboratories now in Colombia 137

11.6.3 Sep 28, 2016: Piramal plans to expand its API development & manufacturing capabilities at Digwal plant 137

12 Appendix 139

12.1 Research Methodology 140

12.1.1 Coverage 140

12.1.2 Secondary Research 140

12.1.3 Primary Research 141

12.1.4 Company Share Analysis 141

12.1.5 Distribution Share Analysis 141

12.1.6 Benchmarking 142

12.2 GlobalData Consulting 142

12.3 Contact Us 143

12.4 Disclaimer 143

1.2 List of Figures

Figure 1: Drug Delivery Devices Market, India, Revenue ($m), USD Constant, 2009-2023 12

Figure 2: Drug Delivery Devices Market, India, Revenue Mix ($m), 2016 14

Figure 3: Drug Delivery Devices Market, India, Category Contribution (%), 2016 15

Figure 4: Drug Delivery Devices Market, India, Category Comparison by Revenue ($m), 2009-2023 16

Figure 5: Drug Delivery Devices Market, India, Revenue ($m), USD Constant, Historic, 2009-2016 17

Figure 6: Drug Delivery Devices Market, India, Revenue ($m), USD Constant, Forecast, 2016-2023 19

Figure 7: Drug Delivery Devices Market, India, Volume (Units), 2009-2023 21

Figure 8: Drug Delivery Devices Market, India, Volume (Units), Historic, 2009-2016 23

Figure 9: Drug Delivery Devices Market, India, Volume (Units), Forecast, 2016-2023 25

Figure 10: Drug Delivery Devices Market, India, Company Share (%) 2016 27

Figure 11: Central Venous Catheters Market, India, Revenue Mix ($m), 2016 29

Figure 12: Central Venous Catheters Market, India, Segment Contribution (%), 2016 30

Figure 13: Central Venous Catheters Market, India, Revenue ($m), USD Constant, Historic, 2009-2016 31

Figure 14: Central Venous Catheters Market, India, Revenue ($m), USD Constant, Forecast, 2016-2023 33

Figure 15: Central Venous Catheters Market, India, Volume (Units), Historic, 2009-2016 35

Figure 16: Central Venous Catheters Market, India, Volume (Units), Forecast, 2016-2023 37

Figure 17: Central Venous Catheters Market, India, Company Share (%) 2016 40

Figure 18: Infusion Systems Market, India, Revenue Mix ($m), 2016 42

Figure 19: Infusion Systems Market, India, Segment Contribution (%), 2016 43

Figure 20: Infusion Systems Market, India, Revenue ($m), USD Constant, Historic, 2009-2016 45

Figure 21: Infusion Systems Market, India, Revenue ($m), USD Constant, Forecast, 2016-2023 47

Figure 22: Ambulatory Infusion Pumps Market, India, Revenue ($m), USD Constant, Historic, 2009-2016 49

Figure 23: Syringe Pumps Market, India, Revenue ($m), USD Constant, Historic, 2009-2016 51

Figure 24: Ambulatory Infusion Pumps Market, India, Revenue ($m), USD Constant, Forecast, 2016-2023 53

Figure 25: Syringe Pumps Market, India, Revenue ($m), USD Constant, Forecast, 2016-2023 55

Figure 26: Infusion Systems Market, India, Volume (Units), Historic, 2009-2016 57

Figure 27: Infusion Systems Market, India, Volume (Units), Forecast, 2016-2023 59

Figure 28: Ambulatory Infusion Pumps Market, India, Volume (Units), Historic, 2009-2016 61

Figure 29: Syringe Pumps Market, India, Volume (Units), Historic, 2009-2016 63

Figure 30: Ambulatory Infusion Pumps Market, India, Volume (Units), Forecast, 2016-2023 65

Figure 31: Syringe Pumps Market, India, Volume (Units), Forecast, 2016-2023 67

Figure 32: Infusion Systems Market, India, Company Share (%) 2016 70

Figure 33: Needle Free Injections Market, India, Revenue ($m), USD Constant, Historic, 2009-2016 72

Figure 34: Needle Free Injections Market, India, Revenue ($m), USD Constant, Forecast, 2016-2023 73

Figure 35: Needle Free Injections Market, India, Volume (Units), Historic, 2009-2016 74

Figure 36: Needle Free Injections Market, India, Volume (Units), Forecast, 2016-2023 75

Figure 37: Needle Free Injections Market, India, Company Share (%) 2016 77

Figure 38: Metered Dose Inhaler Devices Market, India, Revenue ($m), USD Constant, Historic, 2009-2016 79

Figure 39: Metered Dose Inhaler Devices Market, India, Revenue ($m), USD Constant, Forecast, 2016-2023 80

Figure 40: Metered Dose Inhaler Devices Market, India, Volume (Units), Historic, 2009-2016 81

Figure 41: Metered Dose Inhaler Devices Market, India, Volume (Units), Forecast, 2016-2023 82

Figure 42: Metered Dose Inhaler Devices Market, India, Company Share (%) 2016 84

1.1 List of Tables

Table 1: Drug Delivery Devices Market, India, Revenue ($m), USD Constant, 2009-2023 13

Table 2: Drug Delivery Devices Market, India, Category Contribution by Revenue ($m), 2016 15

Table 3: Drug Delivery Devices Market, India, Category Comparison by Revenue ($m), 2009-2023 16

Table 4: Drug Delivery Devices Market, India, Revenue ($m), USD Constant, Historic, 2009-2016 18

Table 5: Drug Delivery Devices Market, India, Revenue ($m), USD Constant, Forecast, 2016-2023 20

Table 6: Drug Delivery Devices Market, India, Volume (Units), 2009-2023 22

Table 7: Drug Delivery Devices Market, India, Volume (Units), Historic, 2009-2016 24

Table 8: Drug Delivery Devices Market, India, Volume (Units), Forecast, 2016-2023 26

Table 9: Drug Delivery Devices Market, India, Company Share by Revenue ($m), USD Constant, 2016 28

Table 10: Central Venous Catheters Market, India, Segment Contribution (%), 2016 30

Table 11: Central Venous Catheters Market, India, Revenue ($m), USD Constant, Historic, 2009-2016 32

Table 12: Central Venous Catheters Market, India, Revenue ($m), USD Constant, Forecast, 2016-2023 34

Table 13: Central Venous Catheters Market, India, Volume (Units), Historic, 2009-2016 36

Table 14: Central Venous Catheters Market, India, Volume (Units), Forecast, 2016-2023 38

Table 15: Central Venous Catheters Market, India, Distribution Share by Revenue ($m), USD Constant, 2015-2016 39

Table 16: Central Venous Catheters Market, India, Company Share by Revenue ($m), USD Constant, 2016 41

Table 17: Infusion Systems Market, India, Segment Contribution (%), 2016 44

Table 18: Infusion Systems Market, India, Revenue ($m), USD Constant, Historic, 2009-2016 46

Table 19: Infusion Systems Market, India, Revenue ($m), USD Constant, Forecast, 2016-2023 48

Table 20: Ambulatory Infusion Pumps Market, India, Revenue ($m), USD Constant, Historic, 2009-2016 50

Table 21: Syringe Pumps Market, India, Revenue ($m), USD Constant, Historic, 2009-2016 52

Table 22: Ambulatory Infusion Pumps Market, India, Revenue ($m), USD Constant, Forecast, 2016-2023 54

Table 23: Syringe Pumps Market, India, Revenue ($m), USD Constant, Forecast, 2016-2023 56

Table 24: Infusion Systems Market, India, Volume (Units), Historic, 2009-2016 58

Table 25: Infusion Systems Market, India, Volume (Units), Forecast, 2016-2023 60

Table 26: Ambulatory Infusion Pumps Market, India, Volume (Units), Historic, 2009-2016 62

Table 27: Syringe Pumps Market, India, Volume (Units), Historic, 2009-2016 64

Table 28: Ambulatory Infusion Pumps Market, India, Volume (Units), Forecast, 2016-2023 66

Table 29: Syringe Pumps Market, India, Volume (Units), Forecast, 2016-2023 68

Table 30: Infusion Systems Market, India, Distribution Share by Revenue ($m), USD Constant, 2015-2016 69

Table 31: Infusion Systems Market, India, Company Share by Revenue ($m), USD Constant, 2016 71

Table 32: Needle Free Injections Market, India, Revenue ($m), USD Constant, Historic, 2009-2016 72

Table 33: Needle Free Injections Market, India, Revenue ($m), USD Constant, Forecast, 2016-2023 73

Table 34: Needle Free Injections Market, India, Volume (Units), Historic, 2009-2016 74

Table 35: Needle Free Injections Market, India, Volume (Units), Forecast, 2016-2023 75

Table 36: Needle Free Injections Market, India, Distribution Share by Revenue ($m), USD Constant, 2015-2016 76

Table 37: Needle Free Injections Market, India, Company Share by Revenue ($m), USD Constant, 2016 78

Table 38: Metered Dose Inhaler Devices Market, India, Revenue ($m), USD Constant, Historic, 2009-2016 79

Table 39: Metered Dose Inhaler Devices Market, India, Revenue ($m), USD Constant, Forecast, 2016-2023 80

Table 40: Metered Dose Inhaler Devices Market, India, Volume (Units), Historic, 2009-2016 81

Table 41: Metered Dose Inhaler Devices Market, India, Volume (Units), Forecast, 2016-2023 82

Table 42: Metered Dose Inhaler Devices Market, India, Distribution Share by Revenue ($m), USD Constant, 2015-2016 83

Table 43: Metered Dose Inhaler Devices Market, India, Company Share by Revenue ($m), USD Constant, 2016 85

Table 44: Drug Delivery Devices Market Pipeline Products 91

Table 45: Pinfold Overseas Acquires Additional 6.4% Stake in Morepen Labs 96

Table 46: Eurolife Healthcare Acquires Form-Fill-Seal Infusion Business from Baxter 97

Table 47: ICU Medical Acquires Hospira Infusion Systems Business from Pfizer 98

Table 48: Piramal Enterprises Plans to Raise Up to USD774.6 Million in Issue of Securities 100

Table 49: Sayre Therapeutics Enters into Licensing Agreement with Navidea Biopharma 101

Table 50: PharmaJet Enters into Agreement with Serum Institute of India 102

Table 51: Aequus Pharma to Enter into Licensing Agreement with Transdermal Research Pharm Labs 103

Table 52: Valeant Pharma Enters into Licensing Agreement with EyeGate Pharma 104

Table 53: Eris Lifesciences Enters into Distribution Agreement with India Medtronic 106

Table 54: Pfizer Terminates its Licensing Agreement with pSivida 107

Table 55: Bayer Enters into Licensing Agreement with DelSiTech 108

Table 56: BioCorRx Enters into Licensing Agreement with Therakine 109

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Teleflex Inc

GlaxoSmithKline Plc

B. Braun Melsungen AG

Baxter International Inc

AstraZeneca Plc

Boehringer Ingelheim GmbH

Fresenius Kabi AG

Pfizer Inc

Smiths Medical

Merck & Co Inc

Cipla Ltd

Hospira Inc

Terumo Corp

Becton Dickinson and Co

Medtronic Plc

Nipro Corp

Drug Delivery Devices, Central Venous Catheters, Needle Free Injections, Infusion Systems, Metered Dose Inhaler Devices, Value (USD), Volume (units), Revenues, Historic Revenues, Forecast Revenues, Average Price, Company Share, Distribution Share by Revenue, Company Share by Revenue, Pipeline Products, News, Deals, Key Companies, GlaxoSmithKline Plc, AstraZeneca Plc, Boehringer Ingelheim GmbH, Pfizer Inc, Merck & Co Inc, Sunovion Pharmaceuticals Inc, Teva Pharmaceutical Industries Ltd, INJEX-Equidyne Systems, Bioject Medical Technologies Inc , Antares Pharma Inc, PharmaJet Inc, MK Global Co., The European Pharma Group, Hospira Inc, Becton Dickinson and Co, Baxter International Inc, Fresenius Kabi AG, Medtronic plc, B. Braun Melsungen AG, Terumo Corp, Smiths Medical, Nipro Corp, JMS Co Ltd

select a license

Single User License
USD 5995 INR 404363
Site License
USD 11990 INR 808726
Corporate User License
USD 17985 INR 1213088

NEWSLETTER BY CATEGORY




Testimonials

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com